Sisätautien yksikkö
Department of Internal Medicine

Julkaisut 2007
Publications 2007

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Rydén L et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
2 Andrulionyté L. Transcription Factors as Candidate Genes for type 2 Diabetes. Studies on Peroxisome Proliferator-Activated Receptors, Hepatic Nuclear Factor 4 Alpha and PPARgamma Coactivator I Alpha.
3 Andrulionyté L et al. Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes. The STOP-NIDDM Trial.
4 Dahlman I et al. A common haplotype in the G-protein-coupled receptor gene GPR74 is associated with leanness and increased lipolysis.
5 Daikeler T et al. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a
6 Erdmann E et al. Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease. Data from the PROactive Study (PROactive 08).
7 Erdmann E et al. The effect of pioglitazone on recurrent myocardial infaraction in 2,445 patients with type 2 diabetes and previous myocardial infarction.
8 Ferrannini E et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk.
9 Ferrannini E et al. Association of fasting glucagon and proinsulin concentrations with insulin resistance.
10 Fueger PT et al. Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat-fed mice. Studies in mice with a 50 % reduction of hexokinase II.
11 Gylling H et al. Cholesterol synthesis prevails over absorption in metabolic syndrome.
12 Gylling H et al. Markers of absorption and synthesis of cholesterol in men with type 1 diabetes.
13 Hakala T et al. Prevention of atrial fibrillation after cardiac surgery.
14 Halinen M. Antikoagulaatiohoito eteisvärinässä.
15 Hallikainen M et al. Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome.
16 Halonen J et al. Sydänleikkauksen jälkeisen eteisvärinän ehkäisy.
17 Halonen J et al. Corticosteroids for the prevention of atrial fibrallation after cardiac surgery.
18 Heikkinen M, Niemelä S. Milloin ruoansulatuskanavan tähystys on syytä toistaa?
19 Heinonen MV et al. Plasma ghrelin levels after two high-carbohydrate meals producing different insulin responses in patients with metabolic syndrome.
20 Heinonen SE et al. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
21 Jantunen E et al. Secondary acute promyelocytic leukemia: An increasingly common entity.
22 Jantunen E, Kataja V. Mukosiitti - syövän hoidon merkittävä pulma.
23 Jokinen JJ et al. Mitral valve replacement versus repair: propensity-adjusted survival and quality-of-life analysis.
24 Juutilainen A et al. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
25 Juutilainen A et al. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
26 Jyrkkiö S et al. Follikulaarisen lymfooman hoito.
27 Järvenpää J et al. Fortified mineral water improves folate status and decreases plasma homocysteine concentration in pregnant women.
28 Kallio P et al. Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons weith the metabolic syndrome: the FUNGENUT study1-4.
29 Keech AC et al. Effect of fenofibrate on the need for treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
30 Kemppainen T et al. No observed local immunological response at cell level after five years of oats in adult coeliac disease.
31 Kharazmi E et al. Reproductive history and carotid intima-media thickness .
32 Kilhovd BK et al. Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study .
33 Kilpeläinen TO et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes.
34 Koistinen P et al. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
35 Kononoff A et al. Intensifying treatment of rheumatoid arthritis with combinations of traditional disease-modifying anti-rheumatic drugs among patients with persistent disease did not reduce the need for large joint surgery.
36 Kozakova M et al. Habitual physical activity and vascular aging in a young to middle-age population at low cardiovascular risk.
37 Kuusisto J et al. Atherosclerosis and cardiovascular risk reduction with PPAR agonists.
38 Kärkkäinen S, Peuhkurinen K. Genetics of dilated cardiomyopathy.
39 Laakso M. Prevention of cardiovascular events in diabetic patients.
40 Laakso M. Challenges in studies of the genetic basis of type 2 diabetes.
41 Laakso M, Groop L. Yksi, kaksi vai monta diabetesta?
42 Laakso M, Kuusisto J. Cerebrovascular disease in type 2 diabetes.
43 Laakso M. Sirtuiinit - energiatasapainon ja glukoosimetabolian uudet molekyylit.
44 Laakso M. Diabetes - glukoosiaineenvaihdunnan säätelyn perinnöllinen häiriö.
45 Laakso M, Uusitupa M. Tyypin 2 diabeteksen ehkäisy.
46 Laaksonen D et al. Physical activity, diet, and incident diabetes in relation to an ADRA2B polymorphism.
47 Laaksonen DE et al. Increased physical activity is a cornerstone in the prevention of type 2 diabetes in high-risk individuals.
48 Lassus J et al. Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.
49 Miettinen KH et al. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy.
50 Niiranen T et al. Home-measured blood pressure is more strongly associated with atherosclerosis than clinic blood pressure: the Finn-HOME Study.
51 Peura P et al. Statiinien teho ja kustannusvaikuttavuus.
52 Pirinen E et al. Enhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism.
53 Purokivi M et al. Utility of hypertonic histamine challenge in distinguishing difficult-to-diagnose asthma.
54 Richelsen B et al. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
55 Rutanen J et al. Single nucleotide polymorphisms of the melanocortin-3 receptor gene are associated with substrate oxidation and first-phase insulin secretion in offspring of type 2 diabetic subjects.
56 Rutanen J et al. Single nucleotide polymorphisms of the MCHR1 gene do not affect metabolism in humans.
57 Saarelainen J et al. Is discordance in bone measurements affected by body composition or anthropometry? A comparative study between peripheral and central devices.
58 Saaristo T et al. National type 2 diabetes prevention programme in Finland: FIN-D2D.
59 Salomaa V et al. Muutokset akuuttien sepelvaltimotapahtumien esiintyvyydessä. FINAMI-tutkimuksen tulokset vuosilta 1993-2002.
60 Saltevo J et al. Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome.
61 Saltevo J et al. Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with the relative change in body mass index between childhood and adulthood.
62 Shiri R et al. The association between carotid intima-media thickness and sciatica .
63 Sipilä K et al. Metabolic syndrome and arterial stiffnes: The health 2000 survey.
64 Sittiwet C et al. Cholesterol metabolism and non-cholesterol sterol distribution in lipoproreins of type 1 diabetes: The effect of improved glycemic control.
65 Soinio M et al. Serum zinc level and coronary heart disease events in patients with type 2 diabetes.
66 Staiger H et al. Genetic variation within the APPL locus is not associated with metabolic or inflammatory traits in a healthy white population.
67 Stefan N et al. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic pysical fitness and insulin sensitivity during lifestyle intervention.
68 Suomalaisen Lääkäriseuran Duodecimin et al. Diabeteksen Käypä hoito -suositus.
69 Tarkiainen TH et al. Comparison of methods for editing of ectopic beats in measurements of short-term non-linear heart rate dynamics.
70 Thorn LM et al. Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy.
71 Tuunanen H et al. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.
72 Udd M et al. Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: A case-control study.
73 Valkamo M et al. Potilaalla on rintakipua ilman vaikeasti ahtauttavaa sepelvaltimotautia - mistä on kyse?
74 Vierimaa O et al. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
75 Vikman S et al. Gender-related differences in the management of non-ST-elevation acute coronary syndrome patients .
76 Vottonen P et al. Electrocardiographic left ventrivular hyperthrophy has low diagnostic accuracy in midddle-aged subjects.
77 Wang J et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
78 Wang J et al. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
79 Wang J et al. Metabolic syndrome and incident end-stage peripheral vascular disease. A 14-year follow-up study in elderly Finns.
80 Weyrich P et al. Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes.
81 Ylä-Herttuala S et al. Vascular endothelial growth factors. Biology and current status of clinical applications in cardiovascular medicine.

Sisätautien yksikkö Department of Internal Medicine
Julkaisutietokanta 18.6.2008 Publications Data Base 18.6.2008